Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Clinical
FDA/EMA/Drug Designation
FDA/EMA/Drug Designation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA/EMA/Drug Designation
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
Biospace News
-
July 16, 2019
FDA/EMA/Drug Designation
Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-ANG3
FDA/EMA/Drug Designation
AstraZeneca’s immunotherapy Imfinzi granted orphan drug status by FDA for small-cell lung cancer
FDA/EMA/Drug Designation
FDA rejects Bausch Health, Eton’s EM-100 for allergic conjunctivitis
FDA/EMA/Drug Designation
AstraZeneca’s immunotherapy Imfinzi granted orphan drug status by FDA for small-cell lung cancer
FDA/EMA/Drug Designation
FDA rejects Bausch Health, Eton’s EM-100 for allergic conjunctivitis
Firstwordpharma News
-
July 12, 2019
0
FDA/EMA/Drug Designation
Govt revokes permit for gene therapy drug Invossa ...
Firstwordpharma News
-
July 4, 2019
0
FDA/EMA/Drug Designation
FDA clears Karyopharm’s nuclear export inhibitor Xpovio for refractory multiple myeloma
Firstwordpharma News
-
July 3, 2019
0
FDA/EMA/Drug Designation
Khondrion granted Orphan Drug Designation for KH176 for the treatment of...
Firstwordpharma News
-
July 2, 2019
0
FDA/EMA/Drug Designation
FDA Action Alert: Karyopharm, Merck and Celgene
Biospace News
-
July 1, 2019
0
1
2
3
...
20
Page 1 of 20
- Advertisement -
MOST POPULAR
Evofem Biosciences Announces Last Patient Enrolled for AMPREVENCE, the Phase 2b...
April 23, 2019
FDA accepts file and accelerates review of Novartis sickle cell disease...
July 16, 2019
Tolero Pharmaceuticals Presents Clinical Data from Ongoing Phase 1 Zella 101...
June 14, 2019
KalVista Pharmaceuticals to Present at Needham Healthcare Conference
April 3, 2019
Load more
HOT NEWS
Others
Amicus and Penn Broaden Gene Therapy Collaboration to Include 12 More...
Others
F-star appoints Dr Louis Kayitalire as Chief Medical Officer
Acquisitions
Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property...
FDA/EMA/Drug Designation
FDA expands first-line NSCLC label for Merck & Co.’s Keytruda
